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Abstract. In the present work, photolysis of N-(2-thiozolyl)sulfanilamide, 2-(4-thiazolyl)benzimidazole 
and thiacetazone in presence of benzophenone as a sensitizer under 125 W UV Lamp has been  
reported. Structures of the products have been established by spectral and elemental analysis. (doi: 
10.5562/cca1677)  




Photolysis of organic compounds has been a vast field 
of research since a long time,1–15 almost all types of 
compounds have been studied so far. However there  
are no reports in the literature on the photolysis of  
N-(2-thiazolyl)sulfanilamide, 2-(4-thiazolyl)benzimid-
azole and thiacetazone. Therefore, in the present work 
we have studied the photolysis of these compounds as 
these are medicinally important compounds having 
pharmacological applications.  
Sulfonamide is an organic sulfur compound con-
taining –SO2NH2 moiety. Its molecular structure is simi-
lar to p-aminobenzoic acid (PABA) which is needed in 
bacteria as a substrate of the enzyme dihydropteroate 
synthetase for the synthesis of tetrahydrofolic acid (THF). 
Sulfonamides, derived from chiefly sulfanilamide, are 
capable of interfering with the metabolic processes in 
bacteria that require PABA.16 They act as antimicrobial 
agents by inhibiting bacterial growth and activity and 
called sulfa drugs.17 They are used in the prevention and 
treatment of bacterial infections, diabetes mellitus,18 
edema,19 hypertension20 and gout.21  
Benzimidazole is a dicyclic compound having im-
idazole ring fused to benzene. Benzimidazole structure 
is a part of the nucleotide portion of vitamin B12 and 
forms the nucleus in some drugs such as proton pump 
inhibitors and anthelmintic agents.22  
Benzimidazol and its derivatives are used in ver-
micides or fungicides as they inhibit the action of cer-
tain microorganisms. Thiabendazole, thiazole substitute 
of benzimidazole is a broad-spectrum benzimidazole 
class anthelmintic with activity against roundworms, 
pinworms, hookworms, and other helminth species which 
attack domestic animals and humans.23 Thiabendazole 
and its salts are general purpose fungicides, bactericides 
and wood preservatives to control mould, blight, and 
other fungal diseases in fruits and vegetables. They are 
also used as preservative in paints, carpets, textiles and 
adhesives.24 Thiabendazole also finds its application as a 
chelating agent to treat metal poisoning.  
Thiacetazone (TAC) is a low cost, antitubercular, 
bacteriostatic drug that has been widely used in combi-
nation with isoniazid in Africa and South America.25 
Chemical analogues of TAC, SRI-224 and SRI-286, 
have been synthesized and tested against Mycobacte-
rium avium and found to be more effective than TAC in 
vitro and in mice.26 It has recently been shown that TAC 
is a prodrug that is activated by the mycobacterial 
monooxygenase EthA, which is also the activator of two 
other anti-tuberculosis drugs, ethionamide (ETH) and 
isoxyl (ISO).27–29 However, the mechanism of action of 
TAC remains an enigma. 
 
EXPERIMENTAL 
The substrates used in the present work are the com-
mercially available compounds of Sigma-Aldrich make 
and are 98 % pure (as claimed by the manufacturer). 
The compounds give single spot on tlc and show sharp 
melting points. 
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Photolysis of N-(2-thiazolyl)sulfanilamide, 2-(4-thia-
zolyl)benzimidazole and Thiacetazone Using UV 
Source 
The substrate (2 g) was dissolved in 200 ml dried and 
distilled methanol. Benzophenone was added as a sensi-
tizer. The solution was irradiated by 125 W UV source 
in neutral, acidic and alkaline medium, respectively in 
photo reactor for appropriate time.  
The progress of the reaction was monitored by 
TLC. After the completion of the reaction, the reaction 
mixture was concentrated. The product was separated 
by preparative TLC using benzene: methanol (8:2) sol-
vent system. The product was washed, dried, and re-
crystallised from methanol. N-(2-thiazolyl)-sulfanil-
amide gave product 2 (Scheme 1) 2-(4-thia-zolyl)benz-
imidazole gave the products 4 and 5 (Scheme 2) and 
thiacetazone gave products 7 and 8 (Scheme 3). Other 
details of the products are given in Table 1. 
 
RESULTS AND DISCUSSION 
Photolysis of N-(2-thiazolyl)sulfanilamide 
N-(2-thiazolyl)sulfanilamide (1) when irradiated by UV 
light in presence of benzophenone, it underwent photol-
ysis giving the product 2 as shown in Scheme 1. The 
structure of the product has been confirmed with the 
help of spectral and elemental analysis data. 
The IR(KBr) spectrum of 2 shows peaks at 
1/ cm  = 3358.3 ν   (NH stretching), 1593.7 (C=N 
stretching), 1084.6 (CN stretching), 828.1 (aromatic CH 
bending) etc. The 1H NMR (DMSO-d6) spectrum gives 
peaks at δ / ppm = 7.2–6.5 (aromatic protons), 3.48 (NH 
and NH2). The 
13C NMR (DMSO-d6) spectrum gives 
peaks at δ / ppm = 152.0 (C=N carbon atom), 141  
(C–S), 135 (C–N), 124–130 (aromatic carbon atoms).  
 
Photolysis of 2-(4-thiazolyl)benzimidazole 
N-(2-thiazolyl)benzimidazole (3) when irradiated by 
UV light in presence of benzophenone it underwent 
photolysis giving the products benzimidazole (4) and 
thiazole (5) as shown in Scheme 2. The structural 
elucidiation of the products has been done by co-TLC 
and mixed melting point with the authenic samples. 
 
Photolysis of Thiacetazone 
Thiactazone (6) when irradiated by UV light in presence 
of benzophenone underwent photolysis giving the prod-
ucts N-phenyl-acetamide (7) and thiourea (8) as shown 
 
Scheme 1. Photolysis of N-(2-thiazolyl)sulfanilamide. 
 
 
Scheme 2. Photolysis of 2-(4-thiazolyl)benzimidazole. 
Table 1. The products obtained by the UV photolysis of N-(2-thiazolyl)sulfanilamide, 2-(4-thiazolyl)benzimidazole and thiacetazone 
Substrate Product Reaction time / h Yield / g Melting point / °C Elemental Analysis (w / %) 
N-(2-thiazolyl)sulfanilamide 
(1) 2 50 1.45 156 
Found: 
C 56.45, H 4.67, S 16.72, 
N 21.91 
Calculated for C9H9N3S: 
C 56.52, H 4.74, S 16.77, 
N 21.97
      
2-(4-thiazolyl)benzimidazole 
(3) 
4 41 0.8 170  
5 41 0.7 223  
      
Thiacetazone 
(6) 
7 51 0.65 165  
8 51 0.72 177  
 
 
Scheme 3. Photolysis of thiacetazone. 
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ucts N-phenyl-acetamide (7) and thiourea (8) as shown 
in Scheme 3. The structural elucidiation of the products 
has been done by co-TLC and mixed melting point with 
the authenic samples. 
 
CONCLUSION 
All the three compounds are photochemically active and 
undergo photodegradation on prolonged exposure to UV 
light. 
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